Condition
Allergy to Shrimp
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
66.7%
2 terminated out of 3 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results33% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Terminated2
Completed1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT03504774Phase 2Terminated
Food Allergen OIT for Shrimp and Cashew
NCT04552522Not ApplicableCompletedPrimary
Immunological Response After Shrimp Oral Immunotherapy Treatment
NCT02490813Not ApplicableTerminated
Pilot Study on Traditional Chinese Medicine and Food Allergy
Showing all 3 trials